Skip to main content

Table 2 Study I echocardiography

From: Systemic and cardiac susceptibility of immune compromised mice to doxorubicin

   2 weeks
BASELINE CONTROL DOXORUBICIN
Parameter Unit MEAN SE MEAN SE MEAN SE
LVAW;d mm 0.83 0.04 0.83 0.04 0.99* 0.15
LVAWS;s mm 1.08 0.06 1.10 0.04 1.33* 0.15
LVID;d mm 3.25 0.08 3.59 0.11 2.64* 0.22
LVID;s mm 2.16 0.08 2.55 0.14 1.53* 0.24
LVPW;d mm 0.79 0.05 0.92 0.08 1.04* 0.07
LVPW;s mm 1.00 0.05 1.08 0.04 1.26* 0.11
Cardiac Output ml/min 11.94 0.91 14.71 1.30 6.82* 1.32
Ejection Fraction % 67.72 1.78 57.87 3.73 76.10 6.35
Fractional Shortening % 36.94 1.33 30.05 2.51 45.31 6.28
Heart Rate BPM 381 18 471 21 352 23
Stroke Volume ul 30.62 1.56 31.30 2.33 18.91* 3.18
Volume;d ul 45.62 2.74 54.64 4.53 26.40* 5.53
Volume;s ul 15.00 1.47 23.34 3.47 7.49* 2.86
  N = 8 m, 4f N = 4 m, 2f N = 4 m, 2f
  1. LV left ventricle, AW anterior wall, ID internal diameter, PW posterior wall, d diastolic, s systolic, BPM beats per minute. *p < 0.05 repeated measures ANOVA